Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review (Q90453420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

1 reference

title

Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

Javad Ameli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Abdolali Banki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Fariborz Khorvash

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Vincenzo Simonetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Nematollah Jonaidi Jafari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Morteza Izadi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

6 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

Acta Biomedica de l'Ateneo Parmense

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

213-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

Geography in multiple sclerosis

14 April 2020

cites work

1 reference

12 December 2020

Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells

1 reference

12 December 2020

Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region

1 reference

12 December 2020

Quantification of adult cerebral hemodynamics by near-infrared spectroscopy

1 reference

12 December 2020

Autohaemotherapy after treatment of blood with ozone. A reappraisal

1 reference

12 December 2020

Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines

1 reference

12 December 2020

Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases

1 reference

12 December 2020

Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today

1 reference

12 December 2020

Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis

1 reference

12 December 2020

Biological and clinical effects of ozone. Has ozone therapy a future in medicine?

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

12 December 2020

Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study

1 reference

12 December 2020

The ozone tolerance: I) Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Ozone Therapy for Tumor Oxygenation: a Pilot Study

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Major ozonated autohemotherapy in chronic limb ischemia with ulcerations

1 reference

12 December 2020

Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease.

1 reference

12 December 2020

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity

1 reference

12 December 2020

Scientific and medical aspects of ozone therapy. State of the art.

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

1 reference

12 December 2020

Neurodegeneration in multiple sclerosis: defining the problem.

1 reference

12 December 2020

Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury

1 reference

12 December 2020

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity

1 reference

12 December 2020

Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct

1 reference

12 December 2020

VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure.

1 reference

12 December 2020

Multiple sclerosis: Geoepidemiology, genetics and the environment

1 reference

12 December 2020

Analysis of the mitochondrial proteome in multiple sclerosis cortex

1 reference

12 December 2020

Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C.

1 reference

12 December 2020

Individual and joint action of environmental factors and risk of MS.

1 reference

12 December 2020

Ozone: a new therapeutic agent in vascular diseases

1 reference

12 December 2020

Adjuvant combined ozone therapy for extensive wound over tibia

1 reference

12 December 2020

XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?

1 reference

12 December 2020

Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?

1 reference

12 December 2020

Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background

1 reference

12 December 2020

Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease

1 reference

12 December 2020

CCSVI is associated with multiple sclerosis

1 reference

12 December 2020

NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells.

1 reference

12 December 2020

Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study

1 reference

12 December 2020

Entropy analysis of muscular near-infrared spectroscopy (NIRS) signals during exercise programme of type 2 diabetic patients: Quantitative assessment of muscle metabolic pattern

1 reference

12 December 2020

Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis.

1 reference

12 December 2020

Revised diagnostic criteria of multiple sclerosis

1 reference

12 December 2020

Does ozone autohemotherapy have positive effect on neurologic recovery in spontaneous spinal epidural hematoma?

1 reference

12 December 2020

Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients

1 reference

12 December 2020

Ozone Therapy and Its Use in Medicine.

1 reference

12 December 2020

Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients.

1 reference

12 December 2020

Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain.

1 reference

12 December 2020

Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients.

1 reference

12 December 2020

Identifiers

DOI

10.23750/ABM.V90I3.7265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31580307%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference